$2.3 Billion Worldwide Digital Dose Inhalers Industry to 2027 – Impact Analysis of COVID-19 – ResearchAndMarkets.com | Financial Buzz

$2.3 Billion Worldwide Digital Dose Inhalers Industry to 2027 – Impact Analysis of COVID-19 – ResearchAndMarkets.com

The “Digital Dose Inhalers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Digital Dose Inhalers estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$5.5 Billion by 2027, growing at a CAGR of 13.1% over the period 2020-2027.

Metered Dose, one of the segments analyzed in the report, is projected to grow at a 12.4% CAGR to reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Dry Powder segment is readjusted to a revised 14.3% CAGR for the next 7-year period. This segment currently accounts for a 35.7% share of the global Digital Dose Inhalers market.

The U.S. Accounts for Over 42.5% of Global Market Size in 2020, While China is Forecast to Grow at a 16.4% CAGR for the Period of 2020-2027

The Digital Dose Inhalers market in the U.S. is estimated at US$992.8 Million in the year 2020. The country currently accounts for a 42.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$480.1 Million in the year 2027 trailing a CAGR of 16.4% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR while Rest of European market (as defined in the study) will reach US$480.1 Million by the year 2027.

Select Competitors (Total 23 Featured) –

  • 3M Company
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Cipla Inc.
  • GlaxoSmithKline plc.
  • Glenmark Pharmaceuticals
  • H&T Presspart Manufacturing Ltd.
  • Koninklijke Philips N.V.
  • Novartis International AG
  • Opko Health, Inc.
  • Philips Respironics
  • Propeller Health
  • Sensirion AG Switzerland
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered:




  • Impact of COVID-19 and a Looming Global Recession
  • COVID-19 Healthcare Emergency Highlights Critical Significance of Digital Dose Inhalers
  • Ongoing Studies Exploring Use of Inhalers-based Therapies to Treat COVID-19
  • COVID-19 Pandemic Pushes Patient Compliance Linked with Inhaler-based Drug Regime
  • An Introduction to Digital Dose Inhalers – Smart Aids to Manage Dose Delivery for Respiratory Conditions
  • Metered Dose Inhalers (MDI)
  • Dry Powder Inhalers (DPI)
  • Global Market Prospects and Outlook: High Prevalence of Respiratory Diseases Keeps Digital Dose Inhalers Market in Hale & Hearty Condition
  • Salient Growth Drivers
  • Analysis by Product: Metered Dose Inhalers Occupy Commanding Share
  • Analysis by Type of Medication: Branded Medications Segment Hold Major Share
  • Regional Analysis: North America to Retain Leadership Position in Digital Dose Inhalers Market
  • Competitive Scenario
  • Recent Market Activity



  • Digital Dose Inhaler Technology Sees Proliferation of IoT
  • Advantages of the IoT-Enabled Digital Dose Inhaler
  • Market to Gain from Ongoing R&D Emphasis on Advanced Treatments for Pulmonary Diseases
  • Established Role of Inhaler Therapy in Respiratory Care Augurs Well
  • Growing Prevalence of Asthma Provides the Perfect Platform for Market Expansion
  • Mounting Burden of COPD Drives Demand for Digital Dose Inhaler Technology
  • Dry Powder Inhalers Set to Make Big Gains
  • Metered Dose Inhalers Continue to Exhibit Sustained Growth Momentum
  • Smart Inhalers Come to the Fore
  • Artificial Intelligence to Add Sophistication to Inhaler Technology
  • New HME Method to Augment Inhaler Technology
  • 3D Printing Seeks Role in Inhaler Manufacturing
  • Uptrend in Healthcare Spending to Result in Improved Opportunities
  • Vulnerability of Growing Geriatric Population to Respiratory Diseases Enhances Prospects for Digital Inhalers




For more information about this report visit https://www.researchandmarkets.com/r/s51aei



Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!